Table 3.
12 h | 24 h | 36 h | 48 h | 60 h | 72 h | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PFS | SFS | PFS | SFS | PFS | SFS | PFS | SFS | PFS | SFS | PFS | SFS | |
(N) | 37 | 39 | 37 | 39 | 37 | 39 | 36 | 39 | 33 | 38 | 24 | 37 |
PRBC | 5%* | 28% | 27% | 26% | 14% | 10% | 6% | 10% | 3% | 5% | 0% | 3% |
Enteral Feeds | 16%* | 0% | 59%* | 28% | 84%* | 49% | 92% | 77% | 84% | 87% | 83% | 78% |
VIS | 3.43 | 7.76* | 5.07 | 7.87 | 3.22* | 6.37 | ||||||
≥2 VAD | 11% | 18% | 16% | 31% | 3%* | 21% |
Highest calculated vasoactive inotropic score during the first, second and third day. (*P < 0.05)
Abbreviations: PFS preemptive fluid strategy, SFS standard fluid strategy, PRBC packed red blood cell transfusion, VAD vasoactive drugs, VIS vasoactive inotropic score